Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 6—June 2017
Dispatch

Clinical and Molecular Characteristics of Human Rotavirus G8P[8] Outbreak Strain, Japan, 2014

Kenji Kondo, Takeshi TsugawaComments to Author , Mayumi Ono, Toshio Ohara, Shinsuke Fujibayashi, Yasuo Tahara, Noriaki Kubo, Shuji Nakata, Yoshihito Higashidate, Yoshiki Fujii, Hirokazu Kimura, Yuko Yoto, and Hiroyuki Tsutsumi
Author affiliations: Sapporo Medical University School of Medicine, Sapporo, Japan (K. Kondo, T. Tsugawa, M. Ono, Y. Yoto, H. Tsutsumi); Tomakomai City Hospital, Tomakomai, Japan (T. Ohara); Tomakomai Children's Clinic, Tomakomai (S. Fujibayashi); Steel Memorial Muroran Hospital, Muroran, Japan (Y. Tahara); Japanese Red Cross Urakawa Hospital, Urakawa, Japan (N. Kubo); Nakata Pediatric Clinic, Sapporo (S. Nakata); Sapporo Hokushin Hospital, Sapporo (Y. Higashidate); National Institute of Infectious Diseases, Tokyo, Japan (Y. Fujii, K. Katayama)

Main Article

Table 2

Genotype constellations and nucleotide identities of strains closely related to To14-0, the representative G8P[8] rotavirus strain used in a study of the clinical and molecular features of a G8P[8] rotavirus outbreak strain, Hokkaido Prefecture, Japan, 2014

Strain (genotype representative from study/country) Genotype constellations and nucleotide identities (%), by gene*
VP7 VP4 VP6 VP1 VP2 VP3 NSP1 NSP2 NSP3 NSP4 NSP5
Human/To14-0 (G8P[8] in study)
G8 (100)
P[8] (100)
I2 (100)
R2 (100)
C2 (100)
M2 (100)
A2 (100)
N2 (100)
T2 (100)
E2 (100)
H2 (100)
Human/VNM/RVN1149/2014/G8P[8] (G8P[8] in Vietnam)
G8 (99.4)
P[8] (99.8)
I2 (99.8)
R2 (99.6)
C2 (99.6)
M2 (99.8)
A2 (100)
N2 (99.9)
T2 (99.5)
E2 (99.9)
H2 (99.5)
Human/THA/NP-130/2014/G8P[8] (G8P[8] in Thailand)
G8 (99.7)
P[8] (99.9)
I2 (99.9)
R2 (99.9)
C2 (99.8)
M2 (99.9)
A2 (99.9)
N2 (99.7)
T2 (99.8)
E2 (99.7)
H2 (99.5)
Human/THA/KKL-17/2013/G8P[8] (G8P[8] in Thailand)
G8 (99.5)
P[8] (99.8)
I2 (91.5)
R2 (99.9)
C2 (99.9)
M2 (99.9)
A2 (99.9)
N2 (99.8)
T2 (99.9)
E2 (99.7)
H2 (99.2)
Human/THA/LS-04/2013/G2P[8] 
(DS-1–like G2P[8] in Thailand)
G2
(–)
P[8] (99.8)
I2 (99.5)
R2 (86.0)
C2 (99.8)
M2 (97.4)
A2 (99.9)
N2 (99.8)
T2 (98.6)
E2 (95.5)
H2 (99.7)
Human/THA/SKT-109/2013/G1P[8] (DS-1–like G1P[8] in Thailand)
G1
(–)
P[8] (99.7)
I2 (98.7)
R2 (86.1)
C2 (99.9)
M2 (99.8)
A2 (99.8)
N2 (85.8)
T2 (99.8)
E2 (94.5)
H2 (99.2)
Human/To14-41 (DS-1–like G1P[8] in study)
G1
(–)
P[8] (98.8)
I2 (98.3)
R2 (86.3)
C2 (99.4)
M2 (99.4)
A2 (99.5)
N2 (85.5)
T2 (99.6)
E2 (93.5)
H2 (98.8)
Human/JPN/NT004/2012/G1P[8] 
(DS-1–like G1P[8] in Japan)
G1
(–)
P[8] (99.0)
I2 (98.4)
R2 (86.3)
C2 (99.7)
M2 (99.5)
A2 (99.5)
N2 (85.6)
T2 (99.6)
E2 (94.5)
H2 (99.2)
Human/THA/NP-M51/2013/G2P[4] (G2P[4] in Thailand)
G2
(–)
P[4]
(–)
I2 (99.5)
R2 (86.0)
C2 (99.1)
M2 (97.5)
A2 (99.0)
N2 (85.4)
T2 (98.7)
E2 (95.5)
H2 (99.7)
Human/KOR/CAU15–11/2015/G2P[4] (G2P[4] in South Korea)
G2
(–)
P[4]
(–)
I2 (99.5)
R2 (85.9)
C2 (99.2)
M2 (97.4)
A2 (94.0)
N2 (84.8)
T2 (98.1)
E2 (95.3)
H2 (98.6)
Human/MU14114 (G2P[4] in study)
G2
(–)
P[4]
(–)
I2 (97.0)
R2 (85.3)
C2 (96.9)
M2 (86.4)
A2 (95.8)
N2 (85.5)
T2 (96.7)
E2 (95.6)
H2 (98.3)
Human/ITA/PR457/2009/G10P[14]
G10
(–)
P[14]
(–)
I2 (93.0)
R2 (98.1)
C2 (82.3)
M2 (86.6)
A11
(–)
N2 (86.4)
T6
(–)
E2 (94.3)
H3
(–)
Caprine/BGL/GO34/1999/G6P[1]
G6
(–)
P[1]
(–)
I2 (94.9)
R2 (86.3)
C2 (83.4)
M2 (86.8)
A11
(–)
N2 (86.6)
T6
(–)
E2 (96.0)
H3
(–)
Human/COD/DRC88/2003/G8P[8] (G8P[8] in Africa)
G8 (86.0)
P[8] (98.3)
I2 (96.3)
R2 (85.6)
C2 (97.4)
M2 (97.0)
A2 (96.4)
N2 (85.8)
T2 (97.1)
E2 (90.1)
H2 (97.4)
Human/MWI/QEC287/2006/G8P[8] (G8P[8] in Africa)
G8 (85.5)
P[8] (98.3)
I2 (96.3)
R2 (85.6)
C2 (97.8)
M2 (96.0)
A2 (96.5)
N2 (86.9)
T2 (96.6)
E2 (89.2)
H2 (97.6)
Human/MWI/QEC289/2006/G8P[8] (G8P[8] in Africa) G8 (85.5) P[8] (97.5) I2 (96.3) R2 (85.5) C2 (97.8) M2 (95.9) A2 (96.5) N2 (86.9) T2 (96.6) E2 (89.2) H2 (97.6)

*Purple indicates G8 genotype; green indicates Wa-like genome segments; red indicates DS-1–like genome segments; bold indicates nucleotide identities >99.0%; – indicates percentages not calculated because the genotype was different that for To14-0.

Main Article

Page created: May 16, 2017
Page updated: May 16, 2017
Page reviewed: May 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external